James M. Isbell, MD, MSCI completed his medical degree at the University of Texas Southwestern Medical School, his general surgery residency at Vanderbilt University Medical Center, his cardiothoracic training at the University of Virginia and surgical critical care training at the University of Virginia and Johns Hopkins. Dr. Isbell is an Associate Professor with dual appointments in the Department of Surgery and the Department of Anesthesiology and Critical Care Medicine at Memorial Sloan Kettering Cancer Center in New York, NY. In addition to his active thoracic surgical practice, he occasionally attends in MSK's ICU and enjoys clinical and translational research. Dr. Isbell leads multiple clinical trials in thoracic oncology. His translational research is focused on the use of liquid biopsy in the diagnosis, treatment and prognosis of lung cancer. He leads an AATS-TSOG-sponsored multicenter study evaluating the predictive and prognositc value of longitudinally monitoring ctDNA levels in patients undergoing neoadjuvant therapy followed by surgical resection for non-small cell lung cancer. He serves as the Director of Quality and Outcomes for the MSK Thoracic Surgery Service, Co-Director of the MSK's Thoracic Liquid Biopsy Progam and Director of MSK's Step-Down Units. He also currently serves as a member of the AATS Thoracic Quality Committee.